Montelukast Tablet, Film Coated
Product Images NDC 50268-556

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 50268-556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 (556 15)

Montelukast Sodium Tablets 10 mg, oral film-coated tablets supplied in bottles of 50 tablets (5 x 10 unit doses). The label shows the product name, strength, quantity, and barcode. It includes storage instructions, usual dosage for adults 15 years and older, and manufacturer information for AvPAK. The label notes the product is prescription-only.*

FDA Label Image

Figure1.jpg (Figure1)

Chemical structure of Montelukast, showing the detailed molecular arrangement with functional groups including chlorine, sulfur, and sodium salt components.*

FDA Label Image

Figure2.jpg (Figure2)

Line graph depicting the mean percent change from baseline over 15 weeks of treatment comparing Montelukast Sodium and placebo. The x-axis shows weeks of treatment including a washout period, and the y-axis shows mean percent change from baseline, indicating a larger improvement with Montelukast Sodium than placebo throughout the treatment duration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.